Neuralink's flashy social media stunts and secrecy around clinical trials betray a dangerous disregard for scientific norms that exist to protect vulnerable patients. The company's selective publicity raises serious informed consent issues, and privately funded neural implant research lacks safeguards ensuring long-term patient support if the technology fails or the company abandons them.